Hunan Jingfeng Pharmaceutical News

*ST Jingfeng: Announcement on Special Risk Alerts

Sep 7 00:00

*ST Jingfeng: Progress announcement on pre-restructuring matters

Aug 31 00:00

*ST Jingfeng: 2024 Semi-Annual Financial Report

Aug 30 00:00

*ST Jingfeng: Semi-annual summary of non-operating capital expenditure and other related capital transactions

Aug 30 00:00

*ST Jingfeng: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024

Aug 30 00:00

*ST Jingfeng: Announcement on Determining Pre-Restructuring Investors and Risk Alerts

Aug 28 00:00

Hunan Jingfeng Pharmaceutical: Announcement from Morgan Stanley (China) Limited on the First Bondholders Meeting of 2024 for the Public Issuance of Corporate Bonds (First Tranche) by Hunan Jingfeng Pharmaceutical Co., Ltd. for Qualified Investors in 2016

Aug 12 18:09

Hunan Jingfeng Pharmaceutical: Announcement Regarding the Postponement of Recruiting Restructuring Investors.

Aug 9 00:00

Hunan Jingfeng Pharmaceutical: Announcement Regarding Special Risk Warning.

Aug 8 00:00

Hunan Jingfeng Pharmaceutical: Announcement on the Public Recruitment of Investors for Restructuring

Aug 2 00:00

Hunan Jingfeng Pharmaceutical: Announcement Regarding Company's Pre-Reshuffle Debt Application

Aug 2 00:00

Hunan Jingfeng Pharmaceutical: Announcement regarding the temporary administrator appointed by the court during the pre-reorganization period of the company.

Aug 1 00:00

Hunan Jingfeng Pharmaceutical: Legal opinion on Hunan Jingfeng Pharmaceutical Co., Ltd.'s First Extraordinary General Meeting of Shareholders in 2024 by Guangdong Chongli Law Firm.

Jul 19 00:00

Hunan Jingfeng Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.

Jul 19 00:00

Hunan Jingfeng Pharmaceutical: The fifth risk warning notice on the possible delisting of company stocks.

Jul 11 00:00

Hunan Jingfeng Pharmaceutical: Announcement regarding the change of venue for the on-site meeting of the first extraordinary shareholders' meeting in 2024.

Jul 10 00:00

Hunan Jingfeng Pharmaceutical: The fourth risk warning announcement regarding the possibility of the company's stocks being delisted.

Jul 10 00:00

Hunan Jingfeng Pharmaceutical: Morgan Stanley (China) Limited's interim report on entrusted management of Hunan Jingfeng Pharmaceutical Co., Ltd.'s 2016 public issuance of corporate bonds (first tranche) for qualified investors (2)

Jul 9 18:25

Hunan Jingfeng Pharmaceutical: The third risk reminder announcement about the company's stocks possibly being delisted.

Jul 9 00:00

*ST Jingfeng: Announcement on the progress of corporate bonds

Jul 6 00:00